• Skip to main content
  • Skip to header right navigation
  • Skip to site footer

786-300-3183 | [email protected]

  • Twitter
  • Facebook
Florida Society of Anesthesiologists

Florida Society of Anesthesiologists

  • About FSA
    • FSA Leadership
      • FSA Past Presidents
      • Distinguished Service Award Past Recipients
      • Recipients of the FSA Presidential Engagement Award
    • FSA Staff
    • FSA NEWS
    • Calendar of Events
    • Contact FSA
    • FSA Charter & Bylaws
    • FSA Speakers Bureau
  • FSA Annual Meeting
    • 2025 Annual Meeting
    • 2024 Annual Meeting Recap
    • Call For Abstracts
    • Past Posters
      • 2025 FSA Podium and Poster Abstracts
      • 2024 FSA Podium and Poster Abstracts
      • 2023 FSA Podium and Poster Abstracts
      • 2022 FSA Podium and Poster Abstracts
      • 2021 FSA Posters
      • 2020 FSA Posters
      • 2019 FSA Posters
      • 2018 FSA Posters
    • Past Meetings
      • 2023 Meeting Recap
      • 2022 Annual Meeting Recap
      • 2019 Annual Meeting Recap
      • 2018 Annual Meeting Recap
  • FSAPAC
    • Donate to the FSAPAC
  • Member Login
  • Member Portal
  • Become a Member
    • FSA Membership Renewal
    • Join the Florida Society of Anesthesiologists (FSA)

2018 FSA Posters

2018 FSA Posters

P028: TRANSNASAL HUMIDIFIED RAPID-INSUFFLATION VENTILATORY EXCHANGE: A NOVEL APPROACH IN MANAGEMENT OF REFRACTORY LARYNGOSPASM
Anwar Mack, MD, Klaus Torp, MD, Elird Bojaxhi, MD; Mayo Clinic

We present a 49-year-old female undergoing dilation of subglottic stenosis who experienced refractory laryngospasm upon emergence. Four episodes of laryngospasm were transiently managed with intravenous boluses of 20mg succinylcholine, 30mg propofol and 20 cmH20 of positive pressure ventilation with jaw-thrust. Patient’s oxygenation ultimately improved with administration of THRIVE and 40% FiO2. Thrive was continued in the PACU, racemic epinephrine was administered for stridor. Patient’s symptoms resolved in the PACU and patient was discharged home. This novel use of THRIVE has yet to be reported in anesthesia literature and may be a viable option for patients experiencing refractory laryngospasm.

Copyright © 2025 · Florida Society of Anesthesiologists · All Rights Reserved